Tandem Diabetes Care (TNDM) EBT Margin Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1,391.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -176.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2,114.00 |
| 10 | Tandem Diabetes Care | 1.17 Bn | 597.96 Mn | 136.79 Mn | 6,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,492.00 |
| Dec 31, 2025 | 895.00 |
| Sep 30, 2025 | 1,306.00 |
| Jun 30, 2025 | -1,752.00 |
| Mar 31, 2025 | -4,274.00 |
| Dec 31, 2024 | -528.00 |
| Sep 30, 2024 | -1,250.00 |
| Jun 30, 2024 | -1,578.00 |
| Mar 31, 2024 | -1,694.00 |
| Dec 31, 2023 | -2,604.00 |
| Sep 30, 2023 | -897.00 |
| Jun 30, 2023 | 907.00 |
| Mar 31, 2023 | -5,789.00 |
| Dec 31, 2022 | -984.00 |
| Sep 30, 2022 | -2,016.00 |
| Jun 30, 2022 | -485.00 |
| Mar 31, 2022 | 2,549.00 |
| Dec 31, 2021 | 38.00 |
| Sep 30, 2021 | 7,725.00 |
| Jun 30, 2021 | 5,176.00 |